Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001140361-16-053997

Options or other derivatives

  • Chief Medical Officer acquired 110,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Faleck Herbert J · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-02-16 Grant or award : show line 1 in the form Stock Option (Right to Purchase) +110,000 $6.99 2026-02-16 110,000 110,000 D
Loading xslF345X03/doc1.xml…